Founded in Aug 2006, Chengdu Sino-strong Pharmaceutical Co.,Ltd is located in Wenjiang cross-straits technological industry park with an area of about 27,000㎡. Sino-strong is a high-tech enterprise focusing on the production of generic drugs and integrating R&D, production and sales. In the meantime, we can also provide a series of professional technical services such as CRO, CDMO and CMO.

Our company has always adhered to an innovative development strategy for many years and received key support from national, provincial and municipal departments at all levels. It has successively won the honorary titles of National High-tech Enterprise, Sichuan Province Construction Innovation Cultivation Enterprise, Chengdu Academician (Experts) Workstation, and "Professional & Specialized " Little Giant awarded by the Ministry of Industry & Information Technology. Up to now, we have 13 registered trademarks, 19 authorized invention patent certificates, and 15 utility model patent certificates.

In recent years, we have focused on independent R&D and innovation in the fields of emergency (rescue), respiratory system, central system, malignant tumors and other ones, and has successfully developed a number of core products covering APIs, important intermediates and preparations, our API production lines can meet the GMP requirements. At present, we have obtained preparation approval documents for 3 products, 22 APIs have passed GMP compliance inspection, 10 APIs have been registered in CDE platform, and there are more than 10 advantageous pharmaceutical intermediates. Our products have been exported to Europe, the Middle East, North and South America, Southeast Asia and other markets.

Founded in December 2020, an off-site production workshop is located in Yuechi County, Guang'an City, covering an area of 69,000 square meters. It was invested and constructed by Chengdu Sino-strong Pharmaceutical Co., Ltd.. which is a modern and industrialized API production base built in strict compliance with the latest safety and environmental standards. The base plans to build 6 automated API synthesis workshops. Based on this, it has successfully established a complete system integrating the research and development, production and sales of high-end chemical APIs, and can provide customers with an end-to-end solution from drug research and development to production, and full process CMO and CDMO service system.

The technology center of our new production workshop has nearly 3,000 square meters of professional R&D space and has established an integrated R&D system for trials, trial amplification and also pilot. In terms of technology, we have mastered the core technology of anti-tumor, anti-thrombotic, cardiovascular, pre-filled injections and other commonly used clinical drugs.

The new production workshop has strong R&D capabilities and R&D team composed of doctors, masters and undergraduates, with a total of 79 team members. Among them, there are 5 doctors and senior engineers, 10 masters, and 61 undergraduates. In addition, 4 industry experts have been hired. Team members cover a wide range of professional fields, involving organic chemistry, pharmacy, biology, polymers, materials chemistry and other fields. With a strong R&D team and a complete quality system, the new production workshop is able to provide partners with higher quality and efficient R&D services.